EMA Authorised: Oczyesa (octreotide hydrochloride) — Camurus AB

View source ↗

Summary

Oczyesa (octreotide hydrochloride) has been authorised for use in the European Union, with Camurus AB as the marketing authorization holder, for the treatment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Oczyesa (octreotide hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Acromegaly. MAH: Camurus AB. Decision date: 02/12/2025